A Study of LY2157299 in Participants With Unresectable Hepatocellular Cancer (HCC)
Clinical trial NCT02240433 · COMPLETED
Trial details
- NCT number
- NCT02240433
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-12
- Primary completion
- 2017-07-19
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.